Clin2
NCT05775458Possibly a fitRecruiting

Study of treatments for aggressive brain tumor cell damage

Brain Tumor, Primary

Part of Brain & nervous system, Cancer clinical trials.

This study looks at glioblastoma (GBM), a very aggressive brain tumor, and how “brain cell overload” (glutamate excitotoxicity) may affect tumor growth. It focuses on adults who are planned for complete tumor removal, followed by standard radiation and chemotherapy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You’re an adult (18 or older).
  • Your brain lesion is suspected to be glioblastoma (GBM) by your care team.
  • Your treatment plan includes complete tumor removal (gross total resection) and then radiation and chemotherapy.
  • You can and will sign informed consent (agree to take part).
  • You do not have serious liver disease.
  • Your blood counts are not too low (hemoglobin is at least 8 mg/dl).
  • You are not pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05664464Recruiting· Phase 1/Phase 2
Glutamate drugs for newly diagnosed brain tumor treatment

This Phase 1/2 study tests whether “glutamate inhibitor” medications can be safely added for newly diagnosed glioblastoma, and how they affect treatment outcomes. It’s designed for adults who will also receive the standard chemo‑radiation plan with temozolomide.

Zurich, Canton of Zurich
NCT06499636Not yet recruiting
Studying tumor samples from children with brain tumors

This study looks at brain tumor samples from children and young adults after surgery to learn more about the tumors and find better treatments. It may help researchers develop new therapies for these tumors.

Roma, Rome
NCT07197086Not yet recruiting
Treatment and outcomes for brain tumor patients

This study looks at how different treatments and patient factors affect outcomes in people with glioblastoma, an aggressive type of brain tumor. By joining, you help researchers learn which approaches work best, which could improve care for future patients.

NCT03005132Recruiting
Study for people with newly diagnosed brain cancer (GBM)

This trial looks at people with glioblastoma (GBM), a fast-growing brain tumor, to better understand it and how treatments might work. You may be able to join if you’re in a good general health range and have not had prior cancer chemotherapy.

Shanghai, Shanghai Municipality
NCT07162324Not yet recruiting
Study for adults with glioblastoma brain cancer

This study is for adults with glioblastoma, a type of brain cancer. Researchers want to gather information about patients with this condition to better understand it and possibly improve future care. By joining, you help doctors learn more about glioblastoma.

San Francisco, California
NCT07731555Recruiting
Studying the brain barrier in glioblastoma

This study looks at how the brain's protective barrier works in people with glioblastoma. Researchers will study tumor tissue and use special scans to learn more, which might help improve future treatments.

Beaumont

Hear when a new Brain Tumor, Primary trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.